Hypertension Manual
Autor A Muruganathanen Limba Engleză Paperback – 22 feb 2024
Preț: 326.45 lei
Preț vechi: 420.12 lei
-22% Nou
Puncte Express: 490
Preț estimativ în valută:
62.50€ • 65.09$ • 51.86£
62.50€ • 65.09$ • 51.86£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789356968349
ISBN-10: 9356968349
Pagini: 464
Dimensiuni: 171 x 241 x 25 mm
Greutate: 0.75 kg
Editura: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD
Colecția Jaypee Brothers,Medical Publishers Pvt. Ltd.
Locul publicării:Delhi, India
ISBN-10: 9356968349
Pagini: 464
Dimensiuni: 171 x 241 x 25 mm
Greutate: 0.75 kg
Editura: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD
Colecția Jaypee Brothers,Medical Publishers Pvt. Ltd.
Locul publicării:Delhi, India
Cuprins
SECTION 1: History and Epidemiology
1. Historical Aspects of Hypertension
SECTION 2: Etiological and Pathophysiological Aspects (Pathogenesis)
2. Overview of Various Pathogenic Mechanisms in Essential Hypertension
3. Renin-Angiotensin-Aldosterone System in Hypertension
SECTION 3: Molecular Basis of Hypertension
4. Role of Cell Membrane (Red Blood Cells and Platelets) in Essential Hypertension
5. Matrix Metalloproteinases and the Extracellular Matrix
6. Role of Calcium Channels in Hypertension
7. Role of Cytokines and Inflammation in Hypertension
8. Natriuretic Peptides in Hypertension
9. Multiple Roles of Eicosanoids in Blood Pressure Regulation
SECTION 4: Accuracy of Blood Pressure Measurement
10. Correct Methodology of Blood Pressure Measurements
11. Home Blood Pressure Monitoring
12. Ambulatory Blood Pressure Monitoring
13. Central Aortic Blood Pressure: An Overview
SECTION 5: Evaluation of Hypertension
14. Hypertension: Clinical Approach
15. Hypertension: Electrocardiogram in Decision Making
SECTION 6: Target Organ Damage: Evaluation and Clinical Importance
16. Hypertensive Retinopathy
SECTION 7: Special Conditions and Situations
17. Hypertensive Crisis
18. Difficult to Control Hypertension (Resistance, Pseudoresistance, and Malignant Hypertension)
19. Hypertension in Pregnancy
20. Metabolic Syndrome and Hypertension
21. White Coat Hypertension and Masked Hypertension
22. Perioperative Hypertension
23. Blood Pressure Variability and Target Organ Damage
24. Exercise and Hypertension
25. Air Pollution and Hypertension
26. Isolated Nocturnal Hypertension
27. Resistant Hypertension
28. Hypertension in Elderly
SECTION 8: Secondary Hypertension
29. Coarctation of Aorta
30. Sleep Apnea and Hypertension
SECTION 9: Therapeutic Aspects: Pharmacologic and Nonpharmacologic Interventions
31. Angiotensin-converting Enzyme Inhibitors: What is New
32. Angiotensin II Receptor Blockers: What is New
33. Calcium Channel Blockers and Hypertension
34. Diuretics and Hypertension
35. Betablockers in Hypertension
36. Alphablockers: Role in Hypertension
37. Direct Vasodilators in Hypertension
38. Hypertensive Heart Disease
39. Emerging Antihypertensive Drugs
40. Combination Therapy in Hypertension
SECTION 10: Genetics and Hypertension
41. Genetic Approaches to Hypertension: Reverence to Human Hypertension
SECTION 11: Interventional Interventions in Hypertension
42. Baroreceptor Stimulation and Hypertension
SECTION 12: Guidelines and Meta-analysis
43. Comparison of Various Guidelines in Hypertension: Which is Best for India
SECTION 13: Miscellaneous
44. Lipid and Hypertension
45. Role of Vitamin D3 and Hypertension
46. Telemedicine and Its Role in the Management of Resistant Hypertension
47. Adherence to the Treatment for Hypertension
48. Navigating Dilemmas in the Management of Hypertension: A Perpetual Challenge
49. Hypertension Clinic and Hypertension Center
1. Historical Aspects of Hypertension
SECTION 2: Etiological and Pathophysiological Aspects (Pathogenesis)
2. Overview of Various Pathogenic Mechanisms in Essential Hypertension
3. Renin-Angiotensin-Aldosterone System in Hypertension
SECTION 3: Molecular Basis of Hypertension
4. Role of Cell Membrane (Red Blood Cells and Platelets) in Essential Hypertension
5. Matrix Metalloproteinases and the Extracellular Matrix
6. Role of Calcium Channels in Hypertension
7. Role of Cytokines and Inflammation in Hypertension
8. Natriuretic Peptides in Hypertension
9. Multiple Roles of Eicosanoids in Blood Pressure Regulation
SECTION 4: Accuracy of Blood Pressure Measurement
10. Correct Methodology of Blood Pressure Measurements
11. Home Blood Pressure Monitoring
12. Ambulatory Blood Pressure Monitoring
13. Central Aortic Blood Pressure: An Overview
SECTION 5: Evaluation of Hypertension
14. Hypertension: Clinical Approach
15. Hypertension: Electrocardiogram in Decision Making
SECTION 6: Target Organ Damage: Evaluation and Clinical Importance
16. Hypertensive Retinopathy
SECTION 7: Special Conditions and Situations
17. Hypertensive Crisis
18. Difficult to Control Hypertension (Resistance, Pseudoresistance, and Malignant Hypertension)
19. Hypertension in Pregnancy
20. Metabolic Syndrome and Hypertension
21. White Coat Hypertension and Masked Hypertension
22. Perioperative Hypertension
23. Blood Pressure Variability and Target Organ Damage
24. Exercise and Hypertension
25. Air Pollution and Hypertension
26. Isolated Nocturnal Hypertension
27. Resistant Hypertension
28. Hypertension in Elderly
SECTION 8: Secondary Hypertension
29. Coarctation of Aorta
30. Sleep Apnea and Hypertension
SECTION 9: Therapeutic Aspects: Pharmacologic and Nonpharmacologic Interventions
31. Angiotensin-converting Enzyme Inhibitors: What is New
32. Angiotensin II Receptor Blockers: What is New
33. Calcium Channel Blockers and Hypertension
34. Diuretics and Hypertension
35. Betablockers in Hypertension
36. Alphablockers: Role in Hypertension
37. Direct Vasodilators in Hypertension
38. Hypertensive Heart Disease
39. Emerging Antihypertensive Drugs
40. Combination Therapy in Hypertension
SECTION 10: Genetics and Hypertension
41. Genetic Approaches to Hypertension: Reverence to Human Hypertension
SECTION 11: Interventional Interventions in Hypertension
42. Baroreceptor Stimulation and Hypertension
SECTION 12: Guidelines and Meta-analysis
43. Comparison of Various Guidelines in Hypertension: Which is Best for India
SECTION 13: Miscellaneous
44. Lipid and Hypertension
45. Role of Vitamin D3 and Hypertension
46. Telemedicine and Its Role in the Management of Resistant Hypertension
47. Adherence to the Treatment for Hypertension
48. Navigating Dilemmas in the Management of Hypertension: A Perpetual Challenge
49. Hypertension Clinic and Hypertension Center
Notă biografică
A Muruganathan MD
Director, Hold Medical Academy, Tirupur, Tamil Nadu, India
Director, Hold Medical Academy, Tirupur, Tamil Nadu, India